Syneron Medical Ltd. To Participate In Three Investor Conferences In November

YOKNEAM, Israel, Nov. 14, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that its management is scheduled to participate in three upcoming investor conferences.

Syneron Medical Ltd logo

The first conference is the Stifel 2014 Healthcare Conference in New York City. Hugo Goldman, Chief Financial Officer, will participate on behalf of the Company.

Conference: Stifel 2014 Healthcare Conference
Date: Tuesday, November 18, 2014
Time: 10:55 am ET

The second conference is the Canaccord Genuity Medical Technology & Diagnostics Forum in New York City. Dr. Shimon Eckhouse, Chairman of the Board of Directors, will participate on behalf of the Company.

Conference: Canaccord Genuity Medical Technology & Diagnostics Forum
Date: Thursday, November 20, 2014
Time: 9:30 am ET

The third conference is the Jefferies 2014 Global Healthcare Conference in London. Mr. Goldman will participate on behalf of the Company.

Conference: Jefferies 2014 Global Healthcare Conference
Date: Thursday, November 20, 2014
Time: 8:00 am GMT (3:00 am ET)

The presentations will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron’s website at www.investors.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentations.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Logo - http://photos.prnewswire.com/prnh/20120528/535447

SOURCE Syneron Medical Ltd.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC